Clinical trial
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal…
NCT00090532 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00090532 |
|---|---|
| Title | A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration |
| Official title | A Phase 1/2, Randomized, Masked, Single and Multiple-Dose, Sequential Dose-Escalation Study of the Safety an Efficacy of AG-013958 in Subjects With Subfoveal Choroidal Neovascularization Associated With Age-related Macular Degeneration |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | AG-013, 958 |
| Enrollment | 155 |
| Start date | Jan 1, 2004 |
| Completion | Aug 1, 2006 |
| First posted | Aug 31, 2004 |
| Last update posted | May 27, 2011 |
| Countries | Australia, Netherlands, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: